T. Şimşek, A. Yılmaz, G. Erdoğan, and E. Peştereli, “Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma”, Gynecol Obstet Reprod Med, vol. 14, no. 3, pp. 189–192, Dec. 2008.